[{"id":"dda9854f-608a-4827-82f0-c0985a5b7f59","acronym":"","url":"https://clinicaltrials.gov/study/NCT05594797","created_at":"2022-10-26T13:56:22.365Z","updated_at":"2024-07-02T16:35:59.318Z","phase":"Phase 2","brief_title":"Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM","source_id_and_acronym":"NCT05594797","lead_sponsor":"Hrain Biotechnology Co., Ltd.","biomarkers":" TNFA • IL2 • IL10 • CRP","pipe":"","alterations":" ","tags":["TNFA • IL2 • IL10 • CRP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e anti-BCMA CAR-T cells"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 07/12/2022","start_date":" 07/12/2022","primary_txt":" Primary completion: 07/31/2025","primary_completion_date":" 07/31/2025","study_txt":" Completion: 07/31/2027","study_completion_date":" 07/31/2027","last_update_posted":"2022-12-09"}]